FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Clinical Decision Software Guide Expands Oversight: Attorneys

Attorneys from DLA Piper complain that a new final FDA guidance on Clinical Decision Support (CDS) Software appears to be more expansive in scope than...

latest-news-card-1
Human Drugs

Eugia Recalls 1 Lot of Acyclovir Sodium Injection

Eugia U.S. (formerly AuroMedics Pharma) recalls one lot of acyclovir sodium injection 500 mg per 10 mL single dose vials due to a product complaint ab...

latest-news-card-1
Human Drugs

Senate OKs Bill Ending Animal Testing Mandates

The Senate unanimously approves legislation to end an FDA mandate for animal testing of experimental drugs before they can be used in human clinical t...

latest-news-card-1
Medical Devices

Medtronics Hemostasis Agent Cleared for Upper GI

FDA clears a Medtronic 510(k) for its Nexpowder endoscopic hemostasis system.

latest-news-card-1
Human Drugs

Amylyx Lou Gehrigs Disease Drug Approved

FDA approves Amylyxs amyotrophic lateral sclerosis (ALS; also known as Lou Gehrig's disease) drug AMX0035 (sodium phenylbutyrate and taurursodiol).

Medical Devices

Radiology Display Device Submission Guidance

FDA publishes a guidance on preparing 510(k) submissions for display devices intended for diagnostic radiology.

latest-news-card-1
Medical Devices

Medical Device Data Systems Guidance

FDA publishes a revised guidance on medical device data systems to conform with the 21st Century Cures Act.

latest-news-card-1
Federal Register

Animal Drug Application Actions Posted

Federal Register notice: FDA amends its animal drug regulations to reflect application-related actions for new animal drug applications and abbreviate...

latest-news-card-1
Federal Register

Meeting on Animal Generic Drug User Fees

Federal Register notice: FDA announces a 10/26 public meeting entitled Animal Generic Drug User Fee Act.

latest-news-card-1
Human Drugs

FDA in New AMP Heart Failure Program

FDA joins with the NIH and other organizations in a new Accelerating Medicines Partnership program on heart failure.